BOWHEAD SPECIALTY ($BOW) posted quarterly earnings results on Tuesday, August 5th. The company reported earnings of $0.37 per share, beating estimates of $0.36 by $0.01. The company also reported revenue of $133,259,999, beating estimates of $129,169,405 by $4,090,594.
You can see Quiver Quantitative's $BOW stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BOWHEAD SPECIALTY Insider Trading Activity
BOWHEAD SPECIALTY insiders have traded $BOW stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BOW stock by insiders over the last 6 months:
- AVA SCHNIDMAN purchased 1,493 shares for an estimated $49,881
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BOWHEAD SPECIALTY Analyst Ratings
Wall Street analysts have issued reports on $BOW in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 05/09/2025
- Piper Sandler issued a "Overweight" rating on 04/16/2025
- JMP Securities issued a "Market Outperform" rating on 04/11/2025
To track analyst ratings and price targets for BOWHEAD SPECIALTY, check out Quiver Quantitative's $BOW forecast page.
BOWHEAD SPECIALTY Price Targets
Multiple analysts have issued price targets for $BOW recently. We have seen 5 analysts offer price targets for $BOW in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- Bob Huang from Morgan Stanley set a target price of $39.0 on 05/19/2025
- Meyer Sheilds from Keefe, Bruyette & Woods set a target price of $45.0 on 05/09/2025
- Paul Newsome from Piper Sandler set a target price of $44.0 on 04/16/2025
- Matthew Carletti from JMP Securities set a target price of $40.0 on 04/11/2025
- Pablo Zuanic from JP Morgan set a target price of $35.0 on 04/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
